Award details

Enhancing potency and efficacy of herpesvirus of turkeys-based multivalent vaccines against avian influenza viruses

Reference	BB/L004240/1
Principal Investigator / Supervisor	Professor Munir Iqbal
Co-Investigators / Co-Supervisors	Professor Venugopal Nair
Institution	The Pirbright Institute
Department	Avian Viral Diseases
Funding type	Research
Value (£)	126,746
Status	Completed
Type	Research Grant
Start date	31/03/2014
End date	30/07/2015
Duration	16 months

Abstract

unavailable

Summary

Avian influenza (AI) viruses of H5N1 and H9N2 subtypes cause severe losses in poultry and pose risks for zoonotic infections. Currently available inactivated vaccines against these viruses are produced in embryonated eggs and have several disadvantages. We have developed a novel live virus vector-based vaccine exploiting herpesvirus of turkeys (HVT) as vaccine vector. The vaccine was prepared in cultured cells, and a single dose of vaccine delivered into eggs before hatch or after hatch induced life-long immunity in vaccinated chickens. Vaccinated birds showed protection against both highly pathogenic AI and Marek's disease when challenged at six week post vaccination. This project will enhance potency and efficacy of the HVT-based AI vaccines that will protect birds at an early age (within three weeks of hatch). In addition, we plan to develop a trivalent vaccine that will protect vaccinated chickens against both H5 and H9 subtypes of avian influenza viruses and Marek's disease.

Committee	Not funded via Committee
Research Topics	Animal Health, Immunology, Microbiology
Research Priority	X – Research Priority information not available
Research Initiative	Follow-On Fund (FOF) [2004-2015]
Funding Scheme	X – not Funded via a specific Funding Scheme

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search